Patient satisfaction with a hepatitis B vaccination programme among persons with an intellectual disability.
This article demonstrates that a patient satisfaction survey can be carried out to evaluate the acceptability of a hepatitis B vaccination programme among persons with an intellectual disability. In this exploratory study, involving six clients, 41 care staff and three managers of intellectual disability services, core themes were identified on the acceptability of the programme. The following recommendations are made: a respectful attitude should be shown to all clients by the healthcare providers; appropriate information about the programme should be provided that is tailored to the needs and receptive capability of all recipients and their carers; the intervention should be delivered in an environment, and by healthcare personnel, familiar to clients; carers should be attentive to the possibility of adverse effects; and explicit, ethically stringent policies should be in place on the use of physical restraint. The article makes suggestions regarding future work in assessing patient satisfaction among this client group.
Cooney
Fionnuala
F
Department of Public Health Medicine, Bridgewater House, Rockwood Parade, Sligo, Ireland. fionnuala.cooney@hse.ie
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003631:Day Care, Medical; D005260:Female; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D017589:Immunization Programs; D007258:Informed Consent; D008607:Intellectual Disability / Q000523:psychology*; D007406:Interview, Psychological; D007494:Ireland; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care / Q000523:psychology*; D010348:Patient Care Team; D017060:Patient Satisfaction; D011369:Professional-Patient Relations; D015397:Program Evaluation; D011785:Quality Assurance, Health Care; D012149:Restraint, Physical / Q000523:psychology; D012931:Social Environment; D055815:Young Adult
C075654:Engerix-B; D017325:Hepatitis B Vaccines